Home About Us Writing a Scientific Article Author's Instruction Contact us
 

MERIT RESEARCH JOURNAL OF MEDICINE AND MEDICAL SCIENCES (MRJMMS) (ISSN: 2354-323X)

 
 

/  /    MRJMMS Home   /   /    About MRJMMS    /  /    Submit Manuscripts    /  /      Call For Articles      / /     Editorial Board     / /    Archive     / /    Author's Guide  /  /

 
 


April 2017 Vol. 5 No.4

Other viewing option


Abstract
• Full text
Reprint (PDF) (341 KB)


Search Pubmed for articles by:
 

Jamal A
Shamsi T

Other links:
PubMed Citation
Related articles in PubMed









































































 




 

Merit Research Journal of Medicine and Medical Sciences (ISSN: 2354-323X) Vol. 5(4) pp. 192-196, April, 2017 

Copyright © 2017 Merit Research Journals


Case Report

Co-occurrence of Oncogenic Driver Mutations (SF3B1, RUNX1 and CSF3R) with Distinct Prognostic Implication in a Lower Risk Myelodysplastic Syndrome Patient

 
 
 

Aisha Jamal1, Nida Anwar2, Saba Shahid3, Shariq Ahmed3, Tahir Shamsi1*

 

1Department of Clinical Haematology and Bone Marrow Transplantation, National Institute of Blood Disease and Bone Marrow Transplantation, ST 2/A block 17 Gulshan-e-Iqbal ,KDA Scheme 24 Karachi, Pakistan
2Department of Haematology, National Institute of Blood Disease and Bone Marrow Transplantation, ST 2/A block 17 Gulshan-e-Iqbal ,KDA Scheme 24 Karachi, Pakistan
3Department of Genomics, National Institute of Blood Disease and Bone Marrow Transplantation, ST 2/A block 17 Gulshan-e-Iqbal, KDA Scheme 24 Karachi, Pakistan

*Corresponding Author’s E-mail: t.shamsi.62@gmail.com
Tel.: 92345-2383956

Accepted April 02, 2017

 

Abstract

 

Recurrent cytogenetic abnormalities are demonstrated in approximately fifty percent cases of Myelodysplastic syndromes (MDS) found as result of genomic instability accredited to the presence of oncogenic genetic mutations. Over the years the molecular basis of MDS has remained elusive but major breakthroughs have been made recently in elucidating the molecular pathogenesis of this entity by employing the sophisticated technology of next generation sequencing. We are reporting here a circumstantial account of a case of Myelodysplastic syndrome with ringed sideroblasts and multilineage dysplasia (MDS-RS-MLD) with normal karyotype and co-occurrence of oncogenic mutations involving SF3B1, CSF3R and RUNX1, deciphered through next generation sequencing. The reports pertinent to the association of SF3B1 mutation to other driver mutations are relatively sparse. It most commonly exists in association with DNMT3A and the two together play an important role in evolution of MDS. RUNX1 mutations are the second common mutations to exist in association with SF3B1. This case points not only towards the diagnostic importance of these somatic driver mutations but also demands for a more refined prognostic model with the integration of somatic driver mutations so that better prognostic groups can be assigned and better risk adapted treatment can be offered to individual MDS patients.

Key words: Myelodysplastic syndrome, Next Generation Sequencing, SF3B1, RUNX1, CSF3R mutation







 










 







































 










 

 
 
   
   
   
   
   
   
   
   
   
   
   
 
 
 
 
 
 
 
 
   
 
                         

Merit Research Journals© 2017 || Advertisement | Privacy policy.